Beyond the Skin: Understanding the relationship between mental health and atopic eczema 

Holly Shaw, Nurse Advisor at Allergy UK

Atopic eczema, also commonly referred to as eczema, affects approximately 20% of children and up to 10% of adults in the UK, making it one of the commonest long-term skin conditions managed in primary care. Although most patients experience mild disease, around 2-4% have severe eczema requiring referral and management by dermatologists.  

Despite its prevalence, eczema is frequently underestimated as a skin condition with minor cosmetic consequences. In reality, persistent itch, dry skin, visible skin lesions, disturbed sleep and repeated flares can significantly impact a person’s physical, emotional, and social wellbeing. 

Management focuses on repairing the damaged skin barrier and controlling inflammation. However, there is increasing recognition that eczema extends far beyond the skin. The psychological burden associated with eczema is significant for children and adults and poor mental health itself can exacerbate disease activity through complex neuroimmune pathways. 

For healthcare professionals, seeing patients with atopic dermatitis, understanding this bidirectional relationship is essential to delivering intergrative care. As primary care clinicians are often responsible for the long-term management of eczema, they are uniquely placed to identify psychological distress, support self-management and intervene before the cycle of stress; itch and inflammation become ingrained. 

The Psychological Burden

A growing body of research demonstrates that patients with eczema are at increased risk of anxiety, depression and reduced quality of life. Psychological distress may arise through several mechanisms: 

  • Chronic itch leading to frustration and emotional exhaustion 
  • Sleep deprivation resulting in fatigue, poor concentration and mood disturbance 
  • Visible skin lesions causing embarrassment, social withdrawal and reduced self-esteem 
  • Recurrent flares leading to feelings of helplessness and loss of control 
  • Burdensome treatment regimens impacting on daily life 
  • Financial hardship through out-of-pocket expenses for topical treatments, specialist clothing and potential loss of income from attending health care appointments.  

The Mind-Skin Connection

The relationship between eczema and mental health is increasingly recognised as bidirectional rather than simply consequential. Psychological stress activates the hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system, releasing stress hormones. These neuroimmune responses influence skin barrier integrity and immune regulation, increasing the likelihood of eczema flares. Active eczema drives psychological stress through chronic itch, discomfort and sleep disruption. 

This creates a well-described itch-scratch cycle. 

Stress increases itch perception → scratching damages the skin barrier → inflammation intensifies → itch worsens → stress increases further. 

Breaking this cycle requires the management of skin disease AND associated psychological distress. 

Sleep Deprivation

Unsurprisingly, sleep disturbance is one of the strongest links between eczema and mental health. Nocturnal pruritus commonly causes multiple nighttime awakenings, reduced sleep quality and chronic sleep deprivation. In children, disrupted sleep is associated with behavioral difficulties, poorer school performance and increased psychological distress. Adults report impaired work productivity, cognitive dysfunction and emotional exhaustion. 

NICE guidance specifically recommends that clinicians assess the impact of eczema on sleep and overall quality of life rather than relying solely on clinical severity scores. 

Routine questions such as “How often does your eczema wake you at night?” can provide valuable insight into disease burden. 

Children, Families and Mental Health

The psychological impact of eczema extends beyond the individual patient and can impact the whole family. Parents of children with eczema often experience significant stress due to disrupted sleep, concerns about treatment, repeated healthcare appointments and the emotional burden of caring for a distressed child. 

Children may experience bullying, embarrassment, and reduced self-confidence because of visible eczema. Adolescents, in particular, may become socially withdrawn at a time when peer acceptance is especially important.  Recognising the impact on the wider family is central to holistic eczema management. 

NICE Guidance Supports Holistic Assessment

NICE quality standards emphasise that clinicians should discuss and document psychological wellbeing and quality of life during eczema consultations. 

Importantly, NICE highlights that there is not always a direct relationship between visible disease severity and psychological impact. Patients with apparently mild eczema may experience substantial emotional distress, while some with severe expressions of eczema cope remarkably well. This strengthens the importance of asking about psychological wellbeing rather than assuming it correlates with skin appearance. 

Practical Assessment in General Practice

Mental health assessment need not substantially lengthen eczema reviews. 

Useful questions include: 

  • How is your eczema affecting your mood? 
  • Are you avoiding work, school, or social situations? 
  • Are you sleeping through the night? 
  • Do you feel anxious about flare-ups? 
  • Is your eczema affecting your confidence or relationships? 

Clinicians should also remain alert to signs of depression, particularly among patients with severe or treatment-resistant disease. 

Management: Treating Both Skin and Mind

Optimising eczema treatment remains a fundamental goal of disease management. Improved disease control frequently results in better psychological wellbeing by reducing itch, improving sleep and restoring confidence. However, addressing mental health directly may also improve eczema outcomes. 

Management may include: 

  • Education regarding the stress–eczema relationship 
  • Optimisation of topical therapies and adherence 
  • Addressing steroid hesitancy  
  • Identification of individual flare triggers 
  • Sleep hygiene advice 
  • Behavioural strategies to reduce scratching 
  • Referral for psychological therapies where appropriate 
  • Social prescribing or peer support groups 
  • Referral to dermatology for patients with uncontrolled disease despite optimal primary care management. 

For patients experiencing significant anxiety or depression, integrated management involving primary care, dermatology, and mental health services may provide the greatest benefit. 

Conclusion

Eczema should no longer be viewed solely as a dermatological condition. Its relationship with mental health is complex, bidirectional, and clinically significant. Psychological distress can worsen inflammation, while chronic eczema can profoundly affect mood, sleep, self-esteem, and social functioning. 

Primary care clinicians are well placed to identify these interactions through routine and holistic assessment. By considering psychological wellbeing alongside physical symptoms, GPs and nurses can improve both dermatological outcomes and overall quality of life. 

As evidence continues to emerge, the merit of integrated management addressing both mental and physical health is likely to become an increasingly important component of high-quality eczema care. 

Observed annually on 14 September, World Atopic Eczema Day raises awareness of the physical, emotional and social impact of atopic eczema. The campaign encourages healthcare professionals, policymakers and the public to recognise eczema as more than skin condition. The 2026 theme, #BreakTheInvisibleBurden, highlights the many unseen challenges faced by people living with eczema, including chronic itch, sleep disruption, anxiety, depression, and reduced quality of life. It is a timely reminder that effective eczema care should address both physical symptoms and psychological wellbeing. 

Reference list:  

  1. National Institute for Health and Care Excellence (NICE). Frequency of application of topical corticosteroids for atopic eczema (TA81). Prevalence and clinical need. 
  2. National Institute for Health and Care Excellence (NICE). Quality Standard QS44: Atopic eczema in under 12s – Quality statement 3: Psychological wellbeing and quality of life. 
  3. National Institute for Health and Care Excellence (NICE). Atopic eczema in under 12s: Diagnosis and management (CG57). 
  4. National Eczema Society. Eczema Unmasked: Not Just a Skin Complaint. 2020. 

Coping with Atopic Dermatitis (Eczema) as an Adult